UPDATE: J.P. Morgan Reiterates on Medtronic Following Solid 2Q Results

In a report published Wednesday, J.P. Morgan analyst Michael Weinstein reiterated a Neutral rating on Medtronic (NYSE: MDT ), and raised the price target from $59.00 to $63.00. In the report, J.P. Morgan noted, “Medtronic reported solid 2Q results Tuesday, as revenues of $4.194B (+2.4%, +3.3% cc) came in $18M